Diplomat Pharmacy (DPLO) Tops Q2 EPS by 4c; Raises Outlook

FREE Breaking News Alerts from StreetInsider.com!

E-mail Address

StreetInsider.com Top Tickers, 11/1/2026

1. INTC
2. AMZN
3. RDDT
4. COIN
5. PINS
6. FSLR
7. SYK
8. DASH
9. GILD
10. SBUX

Go back to Diplomat Pharmacy (DPLO) Tops Q2 EPS by 4c; Raises Outlook

Diplomat Announces 2nd Quarter 2015 Financial Results

August 3, 2015 4:05 PM EDT

FLINT, Mich., Aug. 3, 2015 /PRNewswire/ -- Diplomat Pharmacy, Inc. (NYSE: DPLO), the nation's largest independent specialty pharmacy, announced financial results for the quarter ended June 30, 2015. All comparisons, unless otherwise noted, are to the quarter ended June 30, 2014.

Second Quarter 2015 Highlights include:

Revenue of $808 million, an increase of 49% or $266 million Total prescriptions dispensed of 234,000, an increase of 19% Gross margin of 8.6% versus 5.5% Adjusted EBITDA of $22.7 million, an increase of 287% or $16.8 million Adjusted EPS of... More